论文信息 - Learning to lock down genetic diseases without throwing away the key. - 字舞流文

Learning to lock down genetic diseases without throwing away the key.

Jun Xie | P. Tai

[1] S. Cuzzocrea,et al. Hemophagocytic lymphohistiocytosis following gene replacement therapy in a child with type 1 spinal muscular atrophy , 2022, Journal of clinical pharmacy and therapeutics.

[2] A. Varone,et al. Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study , 2022, Gene Therapy.

[3] S. Mercier,et al. Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy , 2022, Blood advances.

[4] G. Gao,et al. Durability of transgene expression after rAAV gene therapy , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[5] Brian K. Kaspar,et al. Single‐Dose Gene‐Replacement Therapy for Spinal Muscular Atrophy , 2017, The New England journal of medicine.

[6] Mitchell R Lunn,et al. Spinal muscular atrophy , 2008, The Lancet.

[7] C. Lorson,et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8] T. Crawford,et al. The Neurobiology of Childhood Spinal Muscular Atrophy , 1996, Neurobiology of Disease.

[9] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.